Discovery and Management of Adverse Drug Reactions: The Nomifensine Hypersensitivity Syndrome, 1977--1986 (2010)
Abraham, John (Author)
Davis, Courtney (Author)
Social History of Medicine
Volume: 23
Pages: 153--173
Taking the antidepressant, nomifensine, this article focuses on the discovery and management of adverse drug reactions (ADRs) manifested in doctors' spontaneous post-marketing reports. Company-friendly experts, free-lancer research scientists, public servant physicians and regulatory scientists are shown to have made distinct contributions to ADR discovery. However, institutional and international fragmentation delayed synthesis of ADR reports into unambiguous discovery. Qualitative and quantitative interpretative standards of what counted as ADR discovery affected regulatory warning systems and decisions about when to withdraw a drug from the market. The timing and definition of an ADR as `irreversible' or `rare' was, in part, a function of the uncertainty and estimation criteria chosen by the party managing the discovery. UK regulators accepted relatively low levels of uncertainty, so the timing of discovery, warnings and regulatory action was relatively late, but US regulators chose higher thresholds of uncertainty about discovery when interpreting the need to warn of suspected serious ADRs. The implications of these practices for the founding ideals of a post-marketing `early warning system' are considered.
...MoreDescription Comparison of regulatory activities in the US and Great Britain.
Similar Citations
Book
Quirke, Viviane;
Slinn, Judy;
(2009)
Perspectives on Twentieth-Century Pharmaceuticals
(/isis/citation/CBB001022688/)
Book
Fisher, Jill;
(2009)
Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials
(/isis/citation/CBB000953570/)
Article
Kahn, Jonathan;
(2008)
Exploiting Race in Drug Development: BiDil's Interim Model of Pharmacogenomics
(/isis/citation/CBB000953517/)
Book
Parthasarathy, Shobita;
(2007)
Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care
(/isis/citation/CBB000953852/)
Book
Nancy D. Campbell;
(2020)
OD: Naloxone and the Politics of Overdose
(/isis/citation/CBB601007525/)
Thesis
Hanganu-Bresch, Cristina;
(2008)
Faces of Depression: A Study of Antidepressant Advertisements in the American and British Journals of Psychiatry, 1960--2004
(/isis/citation/CBB001561430/)
Book
Carpenter, Daniel;
(2010)
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA
(/isis/citation/CBB001020607/)
Article
Quirke, Viviane;
(2010)
Foreign Influences, National Styles, and the Creation of a Modern Pharmaceutical Industry in Britain and France
(/isis/citation/CBB001000219/)
Article
Kathrin A Hiepko;
(2020)
Where is the Hoechst Insulin?: The Role of Diabetics and Their Doctors as Consumers During the German Democratic Republic’s Autarkic Policy of ‘Making Free From Disturbance’, 1961–1966
(/isis/citation/CBB582523067/)
Thesis
Daemmrich, Arthur Alfred;
(2002)
Therapeutic Cultures: Pharmaceutical Regulation and Medical Politics in the United States and Germany
(/isis/citation/CBB001562513/)
Book
Reid-Henry, Simon;
(2010)
The Cuban Cure: Reason and Resistance in Global Science
(/isis/citation/CBB001033359/)
Article
Tobbell, Dominique A.;
(2009)
“Who's Winning the Human Race?” Cold War as Pharmaceutical Political Strategy
(/isis/citation/CBB000932686/)
Article
Abraham, John;
Davis, Courtney;
(2006)
Testing Times: The Emergence of the Practolol Disaster and Its Challenge to British Drug Regulation in the Modern Period
(/isis/citation/CBB000770617/)
Thesis
Quinn, Roswell;
(2009)
Broader Spectrum: A History of Antibiotic R&D
(/isis/citation/CBB001560664/)
Thesis
Fisher, Jill A.;
(2005)
Pharmaceutical Paternalism and the Privatization of Clinical Trials
(/isis/citation/CBB001561585/)
Article
Sismondo, Sergio;
(2004)
Pharmaceutical Maneuvers
(/isis/citation/CBB000651081/)
Article
Sihn, Kyu-hwan;
(2013)
The Institutionalization of Pharmaceutical Administration after the Korean Liberation: Focusing on Regulating the Pharmaceutical Affairs Law (Yaksabeop) in 1953
(/isis/citation/CBB001214039/)
Article
Herzberg, David;
(2009)
“Will Wonder Drugs Never Cease!”: A Prehistory of Direct-to-Consumer Advertising
(/isis/citation/CBB000933443/)
Article
Podolsky, Scott H.;
Greene, Jeremy A.;
(2009)
Keeping Modern in Medicine: Pharmaceutical Promotion and Physician Education in Postwar America
(/isis/citation/CBB000932130/)
Article
Schondelmeyer, Stephen W.;
(2009)
Recent Economic Trends in American Pharmacy
(/isis/citation/CBB000933448/)
Be the first to comment!